Respiri is an Australian e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US healthcare market. Respiri is listed on the Australian Securities Exchange (ASX) and trades on the OTCQB under the ticker “RSHUF” for North American based investors.
Respiri boasts a world class team consisting of a highly respected Chief Executive Office with a career spanning the healthcare industry, providing valuable experience in medical devices, pharmaceuticals, information systems, technology and sleep disorder solutions. A General Manager of Commercial Operations leading the Commercialisation Team bringing extensive experience in health, successful launches and building teams. An experienced Chief Clinical Officer leading Respiri’s algorithm development and clinical content, and a Chief Technical Officer, with Silicon Valley pedigree, leading the build of the app and data management infrastructure.
The entire team is the driving force behind the new SaaS strategy.
Marjan has been at the helm of Respiri taking it from R&D to commercialisation since 2020. A highly experienced managing director and board member with a career spanning Australia, Europe and Japan, Marjan’s focus has been in the healthcare industry; from pharmaceuticals and information services and technology to medical devices and sleep disorder solutions. He founded and subsequently sold Healthy Sleep Solutions after developing it into a successful business, with ResMed Ltd as a joint venture/shareholder partner.
Currently, Marjan also acts as commercial advisor to Portt, a SaaS company, and is an industry research fellow at University of New South Wales Faculty of Engineering.
Qualifications: BSc (Hons), University of Sydney, Grad Dip Ed, Secondary Education, University of Sydney, MCom Masters of Commerce, University of New South Wales, MAICD, Business Administration, Management and Operations, AGSM, University of New South Wales
With 27 years of experience across MedTech, HIT & Biotech start-ups/emerging growth. Brad currently, serves as CEO, President and BOD of Angel-Medical, a start-up class III implantable cardiology company. Prior to Angel-Med, he served as CEO and BOD of SonaCare Medical (Sonablate Inc.) where he successfully led an exit.
Brad has extensive experience in Sales, Marketing, Operations and fundraising with an emphasis in turnarounds including but not limited to running 3/4 commercial divisions at BTGplc (acquired by Boston Scientific for $4.2B). Previously, Brad held sales and marketing leadership positions at Medlogics, ARAGON Surgical (Acquired B Braun), Fox Hollow Technologies (Acquired $750MM) and RITA Medical (Acquired $220MM).les-Fox Hollow Tech: Acquired $1.5B